Ledger.Open graph →
SEC Form D · Amendment · filed July 17, 2023

Kinaset Therapeutics, Inc

Offering
$41.0M
Sold
$28.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MEDFIELD, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Jamil Beg · Medfield, MADirectorFrazer Morgan · Medfield, MAExec · PromoterKevin Bitterman · Medfield, MADirectorRoger Heerman · Medfield, MAExec · PromoterBram Vanparys · Medfield, MADirectorRobert Clarke · Medfield, MAExec · Director · PromoterTom King · Medfield, MADirectorJay Teich · Branford, CTDirectorQi Zhao · Branford, CTExec · PromoterVenkatasubramanian Viswanathan · Palo Alto, CAExec · PromoterAustin Sendek · Palo Alto, CADirectorDong Wang · Branford, CTDirectorCynthia Green · Branford, CTExec · Director · PromoterChristopher Mcleod · Branford, CTDirectorMario Dattilo · Naples, FLExec · Director · PromoterAndre Basbaum · San Diego, CAExec · PromoterFaith Barnett · San Diego, CADirectorMartha V. Shelley · LOS ANGELES, CADirectorJonah J. Lobel · Miami Beach, FLDirectorDigvijay Chauhan · Seattle, WADirectorNancy Cho · Seattle, WAExec · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗